Clinical Trial Update: Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 extension study is evaluating the long-term safety of relacorilant in patients with Cushing syndrome, and the trial is currently active but not recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cushing Syndrome

Drugs mentioned

• Relacorilant (relacorilant)

Snippet

Sponsor: Corcept Therapeutics | Conditions: Cushing Syndrome | Phase 2 | Status: ACTIVE_NOT_RECRUITING